Business ❯ Corporate Governance ❯ Shareholder Rights

Securities Fraud

False Statements Investor Compensation Litigation Misleading Statements Litigation Outcomes Legal Representation Legal Compliance Legal Investigations Legal Actions Legal Recourse

monday.com Investors Have Until May 11 to Seek Lead Plaintiff in Securities Case

Plaintiff firms are recruiting buyers from late 2025 to early 2026 over claims the company hid slowing revenue expansion.

Nektar Securities Suit Urges Investors To Seek Lead‑Plaintiff Status Before May 5

Navan Securities Suit Seeks Lead Plaintiff as April 24 Deadline Nears

Law Firms Urge Nektar Investors to Seek Lead Role in Securities Suit Over REZOLVE-AA Protocol Claims

Investor Lawyers Press April Deadlines in Lakeland and Navan Securities Cases

Aldeyra Therapeutics Sued in Securities Class Action Over Reproxalap Trial Disclosures

Super Micro Faces Investor Class Actions After DOJ China-Export Indictment

Ultragenyx Hit With Securities Class Action Over Failed Phase III Trials

Plaintiff Firms Intensify Biotech Securities Suits as Key Deadlines Near for Nektar, uniQure and REGENXBIO

Class Actions Filed Against Grocery Outlet After Earnings Miss, Store Closures and $110 Million Charge

Investor Firms Vie to Lead Enphase Securities Class Actions Over Inventory, Tax-Credit Claims

Bath & Body Works Investors Urged to Seek Lead Role in Newly Filed Securities Class Action

CoreWeave Faces Securities Class Action Over Data-Center Delays and Demand Claims

Law Firms Urge Varonis Investors to Seek Lead Role in Securities Suits Before March 9 Deadline

Blue Owl Securities Suits Draw Fresh Investor Notices as Lead-Plaintiff Deadline Nears

DeFi Technologies Investors Face Jan. 30 Deadline in EDNY Securities Class Action

F5 Investors Pressed to Join Securities Suit as Lead‑Plaintiff Deadline Nears

Varonis Hit With Investor Class Actions Over SaaS Conversion Claims and ARR Miss

Skye Bioscience Investors Face Friday Deadline in Securities Class Action Over Nimacimab Disclosures

Varonis Investors Face March 9 Lead Plaintiff Deadline in Securities Class Action